Amphastar Pharmaceuticals, Inc. (AMPH) › RevenueAmphastar Pharmaceuticals, Inc. (AMPH) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $255.16M2017: $240.18M2018: $294.67M2019: $322.36M2020: $349.85M2021: $437.77M2022: $498.99M2023: $644.39M2024: $731.97M2025: $719.89M$719.89M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$719.89M-1.7%2024$731.97M+13.6%2023$644.39M+29.1%2022$498.99M+14.0%2021$437.77M+25.1%2020$349.85M+8.5%2019$322.36M+9.4%2018$294.67M+22.7%2017$240.18M-5.9%2016$255.16M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share